Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to pancreatic cancer?

BACKGROUNDS/AIMS: Gemcitabine is still one of adjuvant options in chemotherapeutic agent for pancreatic ductal adenocarcinoma (PDAC). Integral membrane transporter protein and intracellular enzymes including human equilibrative nucleoside transporter 1 (hENT1), deoxycytidine kinase (dCK), ribonucleo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Dae Wook, Shin, Eun, Cho, Jai Young, Han, Ho-Seong, Yoon, Yoo-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Hepato-Biliary-Pancreatic Surgery 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271117/
https://www.ncbi.nlm.nih.gov/pubmed/32457256
http://dx.doi.org/10.14701/ahbps.2020.24.2.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271117/
https://www.ncbi.nlm.nih.gov/pubmed/32457256
http://dx.doi.org/10.14701/ahbps.2020.24.2.127

Ejemplares similares